[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343707-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343707-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integration-of-epigenomic-and-transcriptomic-profiling-uncovers-ezh2-target-genes-linked-to-cysteine-metabolism-in-hepatocellular-carcinoma","Integration of epigenomic and transcriptomic proﬁling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma","","Integration of epigenomic and transcriptomic profiling identifies EZH2 target genes governing cysteine metabolism in hepatocellular carcinoma. Reanalysis of HCC patient transcriptomes links EZH2 overexpression with poor survival, and tazemetostat restores expression of genes regulating cysteine-methionine metabolism and lipid homeostasis while suppressing angiogenesis and oxidative-stress programs. EZH2 inhibition reverses EZH2-mediated H3K27me3 enrichment at cis-regulatory elements of transsulfuration pathway genes, increasing chromatin accessibility. Among candidate targets, BHMT and CDO1 correlate with worse prognosis, and drug treatment elevates their expression while reducing ferroptosis markers. EZH2 inhibition decreases cell viability and increases lipid peroxidation, supporting rationale for EZH2-targeted therapy in HCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integration-of-epigenomic-and-transcriptomic-profiling-uncovers-ezh2-target-genes-linked-to-cysteine-metabolism-in-hepatocellular-carcinoma/343707/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integration-of-epigenomic-and-transcriptomic-profiling-uncovers-ezh2-target-genes-linked-to-cysteine-metabolism-in-hepatocellular-carcinoma/343707.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was the EZH2-related transcriptional program identified in hepatocellular carcinoma?","Question",{"text":63,"@type":64},"The study integrates epigenomic and transcriptomic analyses, including reanalysis of HCC patient transcriptomic data and effects of selective EZH2 inhibition with tazemetostat.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What changes occur after EZH2 inhibition with tazemetostat?",{"text":68,"@type":64},"Tazemetostat restores genes involved in cysteine-methionine metabolism and lipid homeostasis, suppresses angiogenesis and oxidative-stress-related genes, and reverses EZH2-mediated H3K27me3 enrichment to increase chromatin accessibility.",{"name":70,"@type":61,"acceptedAnswer":71},"Which candidate EZH2 target genes were linked to poor HCC prognosis?",{"text":72,"@type":64},"Among EZH2-targeted candidates, BHMT and CDO1 were notably correlated with poor HCC prognosis, and tazemetostat increased their expression while reducing ferroptosis markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343707,1791088186,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nIntegration of epigenomic and transcriptomic proﬁling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma  \nJaehyun Lee1, Chaelin You1, Geunho Kwon1, Junho Noh1, Kyubin Lee1, Kyunghwan Kim1, Keunsoo Kang2 ✉ and Kyuho Kang 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Enhancer of zeste homolog 2 (EZH2), a key protein implicated in various cancers including hepatocellular carcinoma (HCC), is recognized for its association with epigenetic dysregulation and pathogenesis. Despite clinical explorations into EZH2-targeting therapies, the mechanisms underlying its role in gene suppression in HCC have remained largely unexplored. Here, we integrate epigenomic and transcriptomic analyses to uncover the transcriptional landscape modulated by selective EZH2 inhibition in HCC. By reanalyzing transcriptomic data of HCC patients, we demonstrate that EZH2 overexpression correlates with poor patient survival. Treatment with the EZH2 inhibitor tazemetostat restored expression of genes involved in cysteine-methionine metabolism and lipid homeostasis, while suppressing angiogenesis and oxidative stress-related genes. Mechanistically, we demonstrate EZH2-mediated H3K27me3 enrichment at cis-regulatory elements of transsulfuration pathway genes, which is reversed upon inhibition, leading to increased chromatin accessibility. Among 16 EZH2-targeted candidate genes, BHMT and CDO1 were notably correlated with poor HCC prognosis. Tazemetostat treatment of HCC cells increased BHMT and CDO1 expression while reducing levels offerroptosis markers FSP1, NFS1, and SLC7A11 . Functionally, EZH2 inhibition dose-dependently reduced cell viability and increased lipid peroxidation in HCC cells. Our ﬁndings reveal a novel epigenetic mechanism controlling lipid peroxidation and ferroptosis |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| susceptibility in HCC, providing a rationale for exploring EZH2-targeted therapies in this malignancy. |  |  |\n|  | Cell Death and Disease (2024)15:801; [https://doi.org/10.1038/s41419-024-07198-0](https://doi.org/10.1038/s41419-024-07198-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nHepatocellular carcinoma (HCC), the predominant form of primary liver cancer, accounts for nearly 830,000 cancer-associated mortalities globally every year [1, 2] . While a decline in HCC related to viral infections has been achieved through vaccination, the rise of non-alcoholic steatohepatitis (NASH) and metabolic syndrome signals an alarming increase in HCC cases [3–5] . The multifaceted development of HCC involves cellular alterations such as senescence, mutations, and epigenetic modiﬁcations within a necro-inﬂammatory context, leading to tumorigenesis. As insights emerge that aberrations or genetic variations in epigenetic modulators can broadly inﬂuence cellular biology, culminating in cancer development [6], epigenetic interventions are emerging as a promising therapeutic strategy for HCC [7, 8] . However, the intricate role of epigenetic modulators in the evolution of HCC requires more extensive exploration to deﬁne the optimal strategies for targeting these essential components in combating this challenging disease.  \nEnhancer of zeste homolog 2 (EZH2), the catalytic core of the polycomb repressive complex 2 (PRC2), is fundamental to gene regulation, particularly through its central role in tri-methylating histone 3 lysine 27 (H3K27me3) to suppress gene expression. Remarkably, overexpression of EZH2 has been identiﬁed in various  \ncancers, including HCC, where it exhibits a positive correlation with tumor malignancy [9–11]. Within HCC, the roles of EZH2 extend to the inhibition of NK cell-mediated anti-tumor immunity and the promotion of both carcinogenesis and drug resistance [12–15]. These observations reinforce the perspective that targeting EZH2 could","cbCaisOspXvmxzaf","https://ap.wps.com/l/cbCaisOspXvmxzaf","pdf",9691744,14,"English","# Introduction\n## EZH2 in hepatocellular carcinoma and therapeutic rationale\n## Cysteine metabolism and cancer-related stress responses","[{\"question\":\"How was the EZH2-related transcriptional program identified in hepatocellular carcinoma?\",\"answer\":\"The study integrates epigenomic and transcriptomic analyses, including reanalysis of HCC patient transcriptomic data and effects of selective EZH2 inhibition with tazemetostat.\"},{\"question\":\"What changes occur after EZH2 inhibition with tazemetostat?\",\"answer\":\"Tazemetostat restores genes involved in cysteine-methionine metabolism and lipid homeostasis, suppresses angiogenesis and oxidative-stress-related genes, and reverses EZH2-mediated H3K27me3 enrichment to increase chromatin accessibility.\"},{\"question\":\"Which candidate EZH2 target genes were linked to poor HCC prognosis?\",\"answer\":\"Among EZH2-targeted candidates, BHMT and CDO1 were notably correlated with poor HCC prognosis, and tazemetostat increased their expression while reducing ferroptosis markers.\"}]","Integration of epigenomic and transcriptomic proﬁling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma | PDF",1790051874,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b2a33c4621d2b99ae46a3b4abe12ffd.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/002ffc234f455c6015b297030d8577de.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7f3b90c8ce1a3bd85abb6f9e2b4893b.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c58584a12c70e687b95e20876d18af7c.webp",980,1301]